Neurogene

NGNE

Börsenwert 506 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	BBA 1 Baker Bros. Advisors New York	8,31 Mio. $	+73.845 $	+485	+0,8 %
2	2 Franklin Resources San Mateo, California	4,21 Mio. $	+137.793 $	+905	+3 %
3	3 Broadfin Capital New York	3,69 Mio. $	–	–	–
4	4 Cormorant Asset Management Boston, Massachusetts	1,94 Mio. $	–	–	–
5	5 Visium Asset Management New York	1,63 Mio. $	-1,06 Mio. $	-6.980	-37 %
6	6 Driehaus Capital Management Chicago, Illinois	1,14 Mio. $	-313.193 $	-2.057	-20 %
7	7 Highland Capital Management (Texas) Dallas, Texas	1,09 Mio. $	–	–	–
8	8 Perceptive Advisors New York	902.000 $	–	–	–
9	9 BlackRock Advisors Wilmington, Delaware	801.000 $	–	–	–
10	10 Putnam Investments Boston, Massachusetts	799.000 $	–	–	–
11	11 Royce & Associates New York	783.000 $	–	–	–
12	12 Alyeska Investment Group Chicago, Illinois	683.000 $	+12.028 $	+79	+2 %
13	13 BlackRock Group London, United Kingdom	350.000 $	–	–	–
14	14 Deutsche Bank Frankfurt Am Main Ge, Germany	270.000 $	–	–	–
15	15 Jacobs Levy Equity Management Florham Park, New Jersey	171.000 $	+187.428 $	+1.231	Neu
16	16 BlackRock New York	158.000 $	-10.658 $	-70	-6 %
17	17 UBS Group Zurich, Switzerland	133.000 $	+3.350 $	+22	+2 %
18	18 Geode Capital Management Boston, Massachusetts	111.000 $	–	–	–
19	19 Royal Bank of Canada Toronto, Ontario, Canada	104.000 $	+113.736 $	+747	+24.900 %
20	20 Bridgeway Capital Management Houston, Texas	104.000 $	+114.193 $	+750	Neu
21	21 Spark Investment Management New York	83.000 $	-28.929 $	-190	-24 %
22	22 Bank of Montreal Toronto, Ontario, Canada	27.000 $	–	–	–
23	23 Citigroup New York	8.000 $	-152 $	-1	-2 %
24	24 Tower Research Capital (TRC) New York	6.000 $	+457 $	+3	+8 %
25	25 Walleye Trading New York	6.000 $	+6.090 $	+40	Neu

Neurogene NGNE Börsenwert 506 Mio. $

Neurogene

NGNE

Börsenwert 506 Mio. $